SARS CoV-2 spike protein-guided exosome isolation facilitates detection of potential miRNA biomarkers in COVID-19 infections
- PMID: 36972680
- DOI: 10.1515/cclm-2022-1286
SARS CoV-2 spike protein-guided exosome isolation facilitates detection of potential miRNA biomarkers in COVID-19 infections
Abstract
Objectives: Nearly three years into the pandemic, SARS-CoV-2 infections are occurring in vaccinated and naturally infected populations. While humoral and cellular responses in COVID-19 are being characterized, novel immune biomarkers also being identified. Recently, an increase in angiotensin-converting enzyme 2 expressing (aka, ACE2 positive) circulating exosomes (ExoACE2) were identified in the plasma of COVID-19 patients (El-Shennawy et al.). In this pilot study, we describe a method to characterize the exosome-associated microRNA (exo-miRNA) signature in ACE2-positive and ACE2-negative exosomal populations (non-ExoACE2).
Methods: We performed a sorting protocol using the recombinant biotin-conjugated SARS CoV-2 spike protein containing the receptor binding domain (RBD) on plasma samples from six patients. Following purification, exo-miRNA were characterized for ACE2-positive and ACE2-negative exosome subpopulations by RT-PCR.
Results: We identified differential expression of several miRNA. Specifically let-7g-5p and hsa-miR-4454+miR-7975 were upregulated, while hsa-miR-208a-3p and has-miR-323-3p were downregulated in ExoACE2 vs. non-ExoACE2.
Conclusions: The SARS CoV-2 spike-protein guided exosome isolation permits isolation of ExoACE2 exosomes. Such purification facilitates detailed characterization of potential biomarkers (e.g. exo-miRNA) for COVID-19 patients. This method could be used for future studies to further the understanding mechanisms of host response against SARS CoV-2.
Keywords: ACE2; Covid19; biomarkers; exosomes; miRNAs.
© 2023 the author(s), published by De Gruyter, Berlin/Boston.
References
-
- Del Rio, C, Malani, PN. COVID-19 in 2022-the beginning of the end or the end of the beginning? JAMA 2022;327:2389–90. https://doi.org/10.1001/jama.2022.9655 . - DOI
-
- El-Shennawy, L, Hoffmann, AD, Dashzeveg, NK, McAndrews, KM, Mehl, PJ, Cornish, D, et al.. Circulating ACE2-expressing extracellular vesicles block broad strains of SARS-CoV-2. Nat Commun 2022;13:405. https://doi.org/10.1038/s41467-021-27893-2 . - DOI
-
- Yu, D, Li, Y, Wang, M, Gu, J, Xu, W, Cai, H, et al.. Exosomes as a new Frontier of cancer liquid biopsy. Mol Cancer 2022;21:56. https://doi.org/10.1186/s12943-022-01509-9 . - DOI
-
- Kalluri, R, LeBleu, VS. The biology, function, and biomedical applications of exosomes. Science 2020;367:eaau6977. https://doi.org/10.1126/science.aau6977 . - DOI
-
- Li, S, Yi, M, Dong, B, Tan, X, Luo, S, Wu, K. The role of exosomes in liquid biopsy for cancer diagnosis and prognosis prediction. Int J Cancer 2021;148:2640–51. https://doi.org/10.1002/ijc.33386 . - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous